Huperzine A attenuates mitochondrial dysfunction after middle cerebral artery occlusion in rats

Journal of Neuroscience Research - Tập 86 Số 11 - Trang 2432-2440 - 2008
Chun Yan Zheng1, Haiyan Zhang1, Xi Tang1
1State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, People’s Republic of China

Tóm tắt

AbstractMitochondrial dysfunction has been proved to contribute to ischemia‐induced brain damage. In this study, which used a rat middle cerebral artery occlusion (MCAO) model, the protective effects of huperzine A (HupA) against mitochondrial dysfunction and brain damage were investigated. MCAO for 45 min followed by 4 hr of reperfusion significantly impaired the activities of mitochondrial respiratory chain enzymes (complex I, complex II–III, and complex IV) and α‐ketoglutarate dehydrogenase, increased the production of reactive oxygen species (ROS), and induced mitochondrial swelling. Pretreatment of HupA at 0.1 mg/kg significantly preserved respiratory chain enzyme activities, decreased ROS production, and attenuated mitochondrial swelling. It could also significantly attenuate the neurological deficits (after 4 or 24 hr reperfusion) and reduce infarct volumes (after 24 hr reperfusion). Moreover, HupA protected isolated nonsynaptosomal mitochondria from calcium‐induced damage in vitro by preserving mitochondrial membrane potential and decreasing ROS production. Overall, the present study indicates that HupA can ameliorate MCAO‐induced mitochondrial dysfunction, and this might partially contribute to its protective effect on brain damage after 24 hr of reperfusion. © 2008 Wiley‐Liss, Inc.

Từ khóa


Tài liệu tham khảo

10.1046/j.1471-4159.1995.65041698.x

10.1006/exnr.2000.7438

10.1046/j.1432-1327.1999.00725.x

10.1016/S0006-291X(03)00628-4

10.1016/0003-2697(76)90527-3

10.1016/S1474-4422(07)70005-4

10.1074/jbc.M304854200

10.1023/A:1026111506307

10.1016/j.febslet.2005.04.041

10.1016/S0166-2236(99)01401-0

10.1111/j.1471-4159.1988.tb01115.x

10.1016/0014-5793(93)80498-J

10.1097/00004647-199904000-00001

10.1016/S0304-3940(02)01116-3

10.1016/j.brainres.2005.02.063

10.1038/sj.bjp.0705309

10.1002/jnr.20791

10.1016/0076-6879(67)10043-8

10.1161/01.STR.29.3.705

10.1006/nbdi.1996.0015

10.1046/j.1365-201X.1996.449170000.x

10.1042/BJ20021121

10.1016/0076-6879(79)55008-3

10.1111/j.1471-4159.1986.tb00768.x

Lee JM, 1999, The changing landscape of ischaemic brain injury mechanisms, Nature, 399, A7, 10.1038/399a007

10.1006/exnr.2000.7459

10.1124/jpet.107.122747

10.1016/j.bbrc.2007.07.043

10.1097/00004647-199907000-00002

10.1254/jjp.76.23

10.1016/0361-9230(94)90215-1

10.1038/jcbfm.1988.87

10.1038/jcbfm.1988.144

10.1016/S0091-679X(01)65002-7

10.1016/S0014-5793(00)01082-6

10.1007/BF03402177

10.1161/01.STR.29.10.2162

10.1016/0024-3205(96)00192-0

10.1089/neu.1997.14.573

Siesjo BK, 1999, Role and mechanisms of secondary mitochondrial failure, Acta Neurochir Suppl, 73, 7

10.1111/j.1471-4159.1990.tb04189.x

10.1016/S0197-0186(01)00122-X

10.1016/S0169-328X(98)00172-7

10.1523/JNEUROSCI.1899-04.2004

10.1007/BF01705533

10.1016/S0076-6879(96)64044-0

10.1097/00001756-199703030-00029

10.1038/nature01339

10.1016/S0014-2999(00)00291-0

10.1016/S0006-8993(02)02977-3

10.1159/000085387

10.1016/j.febslet.2007.01.016

10.1016/j.febslet.2007.01.016

10.1016/0076-6879(67)10048-7

10.1016/S0304-3940(00)01088-0

10.1002/1097-4547(20000901)61:5<564::AID-JNR11>3.0.CO;2-X

Yin FM, 2001, Analyze of intervention effect of huperzine A on vascular dementia, Mod Rehabil, 5, 75

10.1016/S0006-8993(99)01733-3

10.1007/s10571-007-9163-z

10.1016/j.tiv.2003.09.002

Zhong ZG, 2004, Clinical observation of effect of huperzine A on 29 vascular dementia patients, J Hainan Med Coll, 10, 251

10.1097/00001756-200107200-00007

10.1016/S0304-3940(01)02265-0